Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-052267

Chief Executive Officer sold 26,712 shares at an average $21.24 ($567,486)

  • Chief Executive Officer acquired 100,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2024-12-18 Sale 10b5-1 −12,653 $20.52 $259,640 3,702,394 D
Anzalone Christopher Richard Chief Executive Officer 2024-12-18 Sale 10b5-1 −8,260 $21.74 $179,572 3,694,134 D
Anzalone Christopher Richard Chief Executive Officer 2024-12-18 Sale 10b5-1 −5,799 $22.12 $128,274 3,688,335 D
Anzalone Christopher Richard Chief Executive Officer 2024-12-18 Grant or award 10b5-1 +100,000 3,788,335 D
Open-market sales · 26,712 sh · avg $21.24 · $567,486
Loading xslF345X05/wk-form4_1734735860.xml…